UCB, a global biopharmaceutical company, today announced it will present 24 abstracts from its expansive neurology portfolio, regarding rare epilepsies Dravet syndrome (DS) and Lennox-Gastaut syndrome ...

Since 2016, the FDA has approved three disease-modifying treatments for spinal muscular atrophy, with several ...

Responders to batoclimab in Period 1, defined as ≥2-point improvement in Myasthenia Gravis Activities of Daily Living (MG-ADL) score from baseline, were re-randomized 1:1:1 to batoclimab (340mg ...

Indeed, although the trial missed its secondary endpoints, intrathecal (IT) Zolgensma (onasemnogene abeparvovec or OAV101 IT) elicited a 2.39-point improvement on the Hammersmith Functional Motor ...

Myasthenia gravis (MG) results from autoimmune antibodies against the post-synaptic neuromuscular junction with three major antibody categories: those to the acetylcholine receptor (AChR antibodies), ...

The Tensilon test was discontinued in the U.S. in 2018. It was performed to help diagnose myasthenia gravis (MG), a neuromuscular junction condition characterized by muscle weakness. The test involved ...

From L.A. and Detroit to Geneva and Tokyo, MotorTrend covers every major auto show in the world as it happens. Although some shows are changing, others are ending, and new ones emerging ...

Detailed price information for Dianthus Therapeutics Inc (DNTH-Q) from The Globe and Mail including charting and trades.

Conti will package its brake components with a patented dual-rotor, radial-flux motor, supplied by DeepDrive, to drive the wheels. The technology will be road-ready soon, the partners say ...

carpal tunnel syndrome cervical and lumbar radiculopathy peripheral neuropathy myasthenia gravis motor neuron disease You also will participate in analyzing and interpreting data leading to ...